1. Home
  2. IMRN vs VS Comparison

IMRN vs VS Comparison

Compare IMRN & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • VS
  • Stock Information
  • Founded
  • IMRN 1994
  • VS 2013
  • Country
  • IMRN Australia
  • VS United States
  • Employees
  • IMRN N/A
  • VS 5
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • VS EDP Services
  • Sector
  • IMRN Health Care
  • VS Technology
  • Exchange
  • IMRN Nasdaq
  • VS Nasdaq
  • Market Cap
  • IMRN 9.2M
  • VS 9.6M
  • IPO Year
  • IMRN N/A
  • VS N/A
  • Fundamental
  • Price
  • IMRN $1.86
  • VS $1.95
  • Analyst Decision
  • IMRN Strong Buy
  • VS Hold
  • Analyst Count
  • IMRN 1
  • VS 1
  • Target Price
  • IMRN $5.00
  • VS $2.00
  • AVG Volume (30 Days)
  • IMRN 55.1K
  • VS 316.4K
  • Earning Date
  • IMRN 08-29-2025
  • VS 08-14-2025
  • Dividend Yield
  • IMRN N/A
  • VS N/A
  • EPS Growth
  • IMRN N/A
  • VS N/A
  • EPS
  • IMRN N/A
  • VS N/A
  • Revenue
  • IMRN $4,777,422.00
  • VS $2,183,196.00
  • Revenue This Year
  • IMRN N/A
  • VS $3,459.21
  • Revenue Next Year
  • IMRN N/A
  • VS N/A
  • P/E Ratio
  • IMRN N/A
  • VS N/A
  • Revenue Growth
  • IMRN 48.63
  • VS 1873.85
  • 52 Week Low
  • IMRN $1.50
  • VS $1.00
  • 52 Week High
  • IMRN $2.87
  • VS $9.59
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 56.87
  • VS 39.75
  • Support Level
  • IMRN $1.73
  • VS $1.80
  • Resistance Level
  • IMRN $1.89
  • VS $2.02
  • Average True Range (ATR)
  • IMRN 0.10
  • VS 0.14
  • MACD
  • IMRN 0.01
  • VS 0.00
  • Stochastic Oscillator
  • IMRN 76.77
  • VS 30.00

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

Share on Social Networks: